Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Amortization - Intangibles (2018 - 2025)

Historic Amortization - Intangibles for Rocket Pharmaceuticals (RCKT) over the last 8 years, with Q3 2025 value amounting to $1.7 million.

  • Rocket Pharmaceuticals' Amortization - Intangibles fell 919.42% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 2781.84%. This contributed to the annual value of $8.1 million for FY2024, which is 2415.74% down from last year.
  • Rocket Pharmaceuticals' Amortization - Intangibles amounted to $1.7 million in Q3 2025, which was down 919.42% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Rocket Pharmaceuticals' Amortization - Intangibles registered a high of $3.3 million during Q4 2023, and its lowest value of -$801000.0 during Q4 2021.
  • In the last 5 years, Rocket Pharmaceuticals' Amortization - Intangibles had a median value of $1.7 million in 2025 and averaged $1.2 million.
  • Per our database at Business Quant, Rocket Pharmaceuticals' Amortization - Intangibles tumbled by 113064.52% in 2021 and then soared by 156089.74% in 2023.
  • Rocket Pharmaceuticals' Amortization - Intangibles (Quarter) stood at -$801000.0 in 2021, then soared by 234.96% to $1.1 million in 2022, then soared by 202.96% to $3.3 million in 2023, then crashed by 62.66% to $1.2 million in 2024, then skyrocketed by 37.29% to $1.7 million in 2025.
  • Its Amortization - Intangibles was $1.7 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.2 million in Q1 2025.